Award
National Institute on Drug Abuse 5R01DA041931-11
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse
Recipient
Albert Einstein College of Medicine
Award Amount
$750,983.00
Ceiling
$750,983.00
Awarded
June 30, 2026
Identifier
5R01DA041931-11
NIH awarded a grant to Albert Einstein College of Medicine to study how buprenorphine affects monocytes in HIV patients with opioid use disorder, aiming to mitigate neurocognitive impairments.
Description
This NIH grant project focuses on the intersection of HIV and opioid use disorder, specifically testing the therapeutic potential of buprenorphine. The project involves in vitro, animal, and human studies to understand mechanisms and develop targeted therapies. It is led by Joan Weinberger Berman at Albert Einstein College of Medicine.